Progress in R&D and key issues in industrial advancement of Cistanches Herba products.
10.19540/j.cnki.cjcmm.20250415.601
- Author:
Shuo YUAN
1
;
Yu-Ling XIAO
1
;
Jia-Xu SUN
1
;
Jun LEI
1
;
Jia-Xin HONG
1
;
Peng-Fei TU
1
;
Yong JIANG
1
Author Information
1. State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Beijing 100191, China.
- Publication Type:English Abstract
- Keywords:
Cistanches Herba;
R&D of products;
cosmetics;
foods;
health foods;
pharmaceuticals
- MeSH:
Drugs, Chinese Herbal/pharmacology*;
Humans;
Cistanche/chemistry*;
Animals;
Medicine, Chinese Traditional
- From:
China Journal of Chinese Materia Medica
2025;50(13):3815-3840
- CountryChina
- Language:Chinese
-
Abstract:
Cistanches Herba(CH) is a famous tonic traditional Chinese medicine, with the effects of tonifying kidney Yang, nourishing kidney Yin, replenishing essence and blood, and moistening the intestines to relieve constipation. Modern pharmacological studies have shown that CH has anti-aging, anti-fatigue, immunomodulatory, neuroprotective, and anti-aging activities, serving as an ideal raw material for the development of pharmaceuticals and health products. In 2023, CH was added in the catalog of medicinal and food substances, which provided policy support for its application in conventional food products and expanding pathways for industrial diversification. To comprehensively understand current development status of CH products, this review systematically investigated professional databases including Yaozhi(https://db.yaozh.com), Chinese Pharmacopoeia, Compendium of National Standards for Chinese Patent Medicines, and Kezhuang and collected market survey data to thoroughly review the applications of CH as a primary ingredient in domestic and international Chinese patent medicines, health foods, cosmetics, and common food products. Furthermore, this review points out challenges in the current industrial development and future potential market prospects, aiming to provide guidance for the development and industrialization of CH-based pharmaceuticals and health products, thereby promoting the vigorous growth of the CH industry.
